GRK Inhibition Potentiates Glucagon-Like Peptide-1 Action.
Seunghun P Lee1, Jenson Qi1, Guozhang Xu2
1Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, PA, United States.
Frontiers in Endocrinology
|May 31, 2021
Summary
Inhibiting G protein-coupled receptor kinases (GRK) enhances glucagon-like peptide-1 receptor (GLP-1R) signaling. This approach improves insulin secretion and glucose metabolism, offering a potential therapeutic strategy.
Area of Science:
- Pharmacology
- Endocrinology
- Molecular Biology
Background:
- Glucagon-like peptide-1 receptor (GLP-1R) activation impacts food intake and glucose metabolism.
- G protein-coupled receptor kinases (GRK) and β-arrestins are key regulators of GLP-1R signaling.
Purpose of the Study:
- To investigate the physiological and pharmacological effects of GRK inhibition on GLP-1R activity.
- To evaluate small molecule inhibitors targeting GRK2 and GRK3.
Main Methods:
- Utilized small molecule inhibitors of GRK2 and GRK3.
- Assessed GLP-1-mediated β-arrestin recruitment.
- Measured GLP-1-induced insulin secretion in isolated islets.
- Evaluated glucose excursion in mice with and without dipeptidyl peptidase 4 inhibition.
Main Results:
- GRK inhibition blocked GLP-1-mediated β-arrestin recruitment.
- Enhanced GLP-1-induced insulin secretion from isolated islets.
- Demonstrated an additive effect with dipeptidyl peptidase 4 in suppressing glucose excursion in mice.
Conclusions:
- GRK plays a crucial role in modulating GLP-1R function both in vitro and in vivo.
- GRK inhibition represents a promising therapeutic strategy to augment GLP-1R signaling for metabolic disorders.
Related Concept Videos
01:24Glucagon-like Receptor Agonists
509
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
509
01:06Oral Hypoglycemic Agents: Glinides
342
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
342
01:09GPCRs Regulate Adenylyl Cylase Activity
6.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.2K
01:23Dipeptidyl Peptidase 4 Inhibitors
315
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
315
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.6K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.6K
01:12GPCR Desensitization
7.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.0K